Feb
2026
Webinar
Neurokinin receptor antagonists represent a new frontier in managing vasomotor symptoms, but many clinicians are still navigating their role in practice. We will review the underlying physiology, summarize available safety and efficacy data, compare agents, and address insurance and access challenges. We’ll also walk through practical prescribing considerations.
We’ll discuss these topics and take your questions in this 60-minute webinar.
February 19, 2026
Speakers: Dr. Rebecca Dunsmoor-Su
5:00 PM Pacific | 6:00 PM Mountain | 7:00 PM Central | 8:00 PM Eastern
March
2026
Webinar
How should clinicians counsel patients about clot risk when considering menopausal hormone therapy? We’ll review the data on transdermal vs. oral estrogen, differing progestogens, and risk in special populations. We’ll also cover strategies for shared decision-making and communicating nuanced risk in a clear, supportive way.
We’ll discuss these topics and take your questions in this 60-minute webinar.
March 19, 2026
Speakers: Dr. Rebecca Dunsmoor-Su
4:00 PM Pacific | 5:00 PM Mountain | 6:00 PM Central | 7:00 PM Eastern
April
2026
Webinar
Changes in body composition during menopause can be distressing and often misunderstood. We’ll review what is known about fat redistribution, muscle loss, and metabolic shifts in midlife. We’ll discuss how to frame these changes for patients, address body image concerns, and guide women toward realistic goals for long-term health, strength, and metabolic resilience.
We’ll discuss these topics and take your questions in this 60-minute webinar.
April 15, 2026
Speakers: Dr. Rebecca Dunsmoor-Su
5:00 PM Pacific | 6:00 PM Mountain | 7:00 PM Central | 8:00 PM Eastern